Botox is FDA-approved to prevent chronic migraine (15+ headache days a month). Learn how it works, the 31-injection protocol, realistic results, side effects, and what it costs, clinician-reviewed.
Botox (onabotulinumtoxinA) is FDA-approved to prevent chronic migraine in adults with 15 or more headache days a month. A clinician injects 155 units across 31 sites in the head and neck every 12 weeks, which can reduce how often and how severely migraines strike.
| Preventive option | Form and frequency | Approved for | Key trade-off |
|---|---|---|---|
| Botox (onabotulinumtoxinA) | 31 injections every 12 weeks, in-office | Chronic migraine (FDA-approved) | Needles and clinic visits; benefit builds over months |
| Oral preventives (e.g. topiramate, beta-blockers, amitriptyline) | Daily pills at home | Migraine prevention (varies by drug) | Inexpensive but daily side effects cause many to quit |
| CGRP inhibitors | Monthly/quarterly self-injection or oral | Episodic and chronic migraine | Migraine-specific and convenient; coverage and cost vary |
| Rescue/acute medications | Taken at onset of attack | Stopping an active attack | Not preventive; overuse can worsen headaches |
If you live with migraine on more days than not, you have probably read that Botox can help, and also that it is expensive, involves dozens of needles, and does not work for everyone. All of that is true at once, which is why the details matter. This guide explains exactly what Botox does for migraine, who it is approved for, what an appointment looks like, the results the clinical evidence actually supports, the risks, and what treatment costs with and without insurance.
One point to be clear about up front: Botox is FDA-approved for chronic migraine specifically, meaning 15 or more headache days per month. It is not FDA-approved for occasional or episodic migraine, and using it that way is off-label. Botox is a preventive treatment, not a rescue medication and not a cure. This page is educational and is not a substitute for advice from your own physician or neurologist.
Botox is a purified form of botulinum toxin type A, the same neuromodulator used cosmetically to soften wrinkles. In cosmetic use it relaxes muscles that crease the skin. In migraine prevention it works differently, and that difference is the key to understanding the treatment. Botox does not simply paralyze the muscles that make your head hurt. Instead, it is thought to block the release of pain-signaling chemicals, including a neurotransmitter called acetylcholine and pain peptides such as CGRP and substance P, at the nerve endings around the head and neck.
By dampening these signals at the sensory nerves, Botox is believed to turn down the activation of the pain network that drives migraine, including the trigeminal system. In practical terms, it makes the nervous system less likely to fire off the cascade that becomes a migraine attack. This is why it is used preventively, on a fixed schedule, rather than at the moment a headache begins. It quietly reduces the frequency and intensity of future attacks over weeks, rather than stopping an attack already underway.
It is worth being honest that the full mechanism is still not completely understood, even though the treatment is well studied and FDA-approved. What is established is that the injections are placed in a specific, standardized pattern across muscles of the forehead, temples, back of the head, neck, and shoulders, and that this pattern was refined through large clinical trials rather than chosen at random.
Botox received FDA approval for chronic migraine in 2010. The approved population is adults whose migraine has become chronic, which clinicians define as 15 or more headache days per month, with each qualifying headache lasting 4 hours or longer, for at least 3 months, and at least 8 of those days having migraine features. Meeting this threshold is what separates a Botox candidate from someone with fewer headache days.
If you have episodic migraine, meaning fewer than 15 headache days a month, Botox is not FDA-approved for you, and using it in that situation is off-label. Off-label does not automatically mean unsafe or unreasonable, but the strong clinical evidence for Botox is specifically in chronic migraine, and the episodic evidence has generally not shown a clear benefit over placebo. A responsible provider will tell you plainly which side of that line you fall on.
Most guidelines and insurers also expect that you have already tried other preventive migraine medications, often two or more from different drug classes, without adequate relief or with intolerable side effects, before Botox is used. Botox is generally avoided during pregnancy and breastfeeding, and in people with certain neuromuscular disorders such as myasthenia gravis or ALS, or with an infection at the planned injection sites. Screening for these situations is part of a proper consultation, not an afterthought.
Migraine treatment follows a standardized protocol established in the PREEMPT clinical trials, and it looks quite different from a cosmetic Botox visit. The standard dose is 155 units of Botox delivered through 31 small injections, distributed across seven specific muscle groups on both sides of the head and neck: the forehead, the frown-line area between the brows, the temples, the back of the head, the upper neck, and the tops of the shoulders. Some providers add extra injections using a follow-the-pain approach for a higher total dose in select patients.
The injections use a very fine needle and go into muscle just under the skin. Most people describe the sensation as a series of quick pinches or small stings rather than sharp pain, and the whole appointment usually takes only 10 to 20 minutes. No anesthesia is required, though some clinics offer ice or a cold pack to reduce discomfort. You can typically drive yourself home and return to normal activities the same day, avoiding rubbing the injection sites and strenuous exercise for a few hours.
Crucially, Botox for migraine is given on a fixed cycle: once every 12 weeks. It is not a one-time or as-needed treatment. Because the benefit builds gradually over successive cycles, most neurologists ask patients to complete at least two full rounds, roughly six months, before judging whether it is working. Skipping or stretching out cycles undercuts the preventive effect, so consistency matters more here than with almost any cosmetic use.
The evidence for Botox in chronic migraine comes largely from the PREEMPT program, two large randomized, placebo-controlled trials. In the pooled results, patients treated with Botox had on average about 8.4 fewer headache days per month after 24 weeks, compared with about 6.6 fewer days in the placebo group. That difference is statistically real and clinically meaningful for many people, but it is honest to note that the placebo group also improved substantially, and Botox is not a cure. It reduces the burden of migraine; it rarely eliminates it.
Response is also not immediate. Many patients notice little change after the first cycle and see the clearest benefit only after the second or third round. This is why the six-month, two-cycle trial period is standard before deciding whether to continue. Roughly speaking, a good outcome is defined as at least a 50 percent reduction in headache days, and while a substantial share of patients reach that mark, a meaningful minority do not respond and stop treatment.
For those who do respond, the benefit of each treatment lasts about 10 to 12 weeks, which is why re-injection is scheduled at 12-week intervals. The effect wears off gradually as nerve function returns, so headaches tend to creep back toward the end of a cycle rather than switching off suddenly. Over time, with consistent treatment, some patients find their migraine pattern becomes more manageable overall. Individual results vary widely, and no injector can honestly guarantee a specific number of headache-free days.
For migraine prevention, Botox has a well-characterized safety profile, and most side effects are mild and temporary. The most common is neck pain or neck stiffness, which makes sense given that several injections go into neck and shoulder muscles. Other frequent effects include injection-site soreness, temporary headache in the day or two after treatment, and minor bruising or redness. These typically settle within a few days.
Because Botox relaxes muscle, misplacement or unwanted spread can cause a drooping eyelid or brow, temporary muscle weakness in the neck, or an uneven appearance of the forehead. These are usually placement-related, resolve as the toxin wears off over weeks to a few months, and are much less likely with an experienced injector using the standardized pattern. Some people feel mild neck weakness that makes holding the head up briefly uncomfortable, particularly after the first cycle.
Serious complications are rare at the doses used for migraine. The FDA requires a boxed warning noting that, in principle, the toxin can spread from the injection area and cause symptoms such as difficulty swallowing, speaking, or breathing, or generalized muscle weakness. These effects are very uncommon at migraine doses, but they are the reason you should seek medical care immediately if you experience trouble swallowing or breathing after treatment. Telling your provider about all medications, especially other muscle relaxants or certain antibiotics, and any neuromuscular condition, is an important safety step.
Cost is one of the most common questions, and the honest answer is that it depends heavily on insurance. The Botox itself for a migraine session uses 155 units, and at typical medical pricing the drug plus the injection visit can amount to a substantial out-of-pocket figure per treatment if paid entirely in cash, potentially well over a thousand dollars every 12 weeks. Because prices vary by region, provider, and negotiated rates, we do not quote a fixed number here; ask for a written estimate before you commit.
The good news is that, unlike cosmetic Botox, migraine treatment is often covered by health insurance, precisely because it is an FDA-approved medical indication. Most plans, including many commercial insurers, Medicare, and Medicaid, will cover Botox for chronic migraine when specific criteria are met. Those criteria usually include a documented diagnosis of chronic migraine with 15 or more headache days a month and evidence that you have tried and failed at least two other preventive medications.
Coverage almost always requires prior authorization, and denials on the first submission are common, so persistence and thorough documentation from your neurologist matter. The manufacturer also runs a patient savings program that can reduce out-of-pocket costs for eligible, commercially insured patients, and some clinics help with the authorization paperwork. When comparing providers, it is fair to ask not only about their injection experience but also about how they handle insurance and prior authorization, because that support can make the difference between an affordable treatment and an unaffordable one.
Botox is one option among several preventive strategies, and it is rarely the first thing tried. Standard oral preventives, including certain blood pressure medications, antidepressants, and anti-seizure drugs such as topiramate, are usually attempted first because they are inexpensive and taken at home, though many people stop them because of daily side effects. Botox appeals to patients who cannot tolerate or did not benefit from these pills, since it is dosed only four times a year.
A newer class of migraine-specific preventives, the CGRP inhibitors, has changed the landscape. Some are monthly or quarterly injections you can give yourself at home, and others are daily or intermittent pills. They were designed specifically for migraine and are effective for many patients, including some with episodic migraine, where Botox is not approved. Direct comparisons suggest Botox and CGRP treatments are broadly comparable in effectiveness for chronic migraine, and some specialists use them together in difficult cases.
The table below summarizes how these options differ on the attributes that usually drive the decision. The right choice depends on how many headache days you have, what you have already tried, your tolerance for needles versus daily pills, and your insurance. This is a conversation to have with a headache specialist rather than a decision to make from a web page.
Botox for migraine is a medical treatment, not a cosmetic one, and that shapes who should perform it. The standardized 31-injection protocol is most often delivered by neurologists, particularly headache specialists, though some pain-medicine physicians and appropriately trained clinicians also offer it. This is not the same as walking into a med spa for a cosmetic touch-up; the goal, the dosing, and the injection map are different, and proper diagnosis of chronic migraine has to come first.
When choosing a provider, look for someone who treats migraine regularly, follows the evidence-based PREEMPT protocol, and is transparent about realistic expectations, including the fact that benefit builds over two to three cycles and that not everyone responds. A good provider will confirm your diagnosis, review what preventives you have already tried, screen for reasons to avoid Botox, and help navigate insurance authorization rather than pushing cash payment.
If you and your physician decide Botox is worth trying, the next practical step is connecting with a qualified injector who handles migraine treatment. Because coverage, protocol adherence, and honest candidacy screening vary between practices, it is worth comparing providers rather than defaulting to the first one you find. When you are ready, you can use the link below to find a qualified injector and start that conversation.
The main downsides are that it does not work for everyone, benefit builds slowly over two to three cycles, and it means 31 injections every 12 weeks indefinitely. Common side effects include neck pain and injection-site soreness, and cost can be high without insurance approval.
Often yes, because it is an FDA-approved medical treatment. Most commercial plans, Medicare, and Medicaid cover it when chronic migraine (15 or more headache days a month) is documented and you have tried other preventives. Prior authorization is almost always required, and first-time denials are common.
Most people describe the 31 injections as a series of quick pinches or small stings rather than sharp pain. The needle is very fine and the appointment takes only 10 to 20 minutes. Ice or a cold pack can ease discomfort, and no anesthesia is needed.
It is not immediate. Some people notice a change within a couple of weeks of the first session, but many see the clearest benefit only after the second or third cycle. Most specialists advise completing at least two rounds, about six months, before deciding if it works.
Botox has been used for chronic migraine since its 2010 approval and can be continued long term when it helps and is tolerated. It is given every 12 weeks on an ongoing basis. Your physician monitors response and side effects at each visit to decide whether to continue.
"Ocular migraine" usually means migraine with visual aura: shimmering zigzag lights or a blind spot that builds over 5-20 minutes and clears within an hour. It often needs no acute drug: rest in a dim room, then treat any headache that follows. Frequent attacks warrant preventive therapy.
Two different things get called ocular migraine. Visual aura affects the same half of the visual field in both eyes and reflects a wave of cortical activity: it is benign and self-limiting. True retinal migraine causes vision loss in one eye only (cover each eye to check) and needs ophthalmology and neurology evaluation; triptans and ergotamines are generally avoided in it. A first-ever episode of visual disturbance without headache must be evaluated urgently to exclude TIA or stroke. Call 911 for visual symptoms that start suddenly at full intensity, fail to resolve within 60 minutes, or come with face droop, weakness, or speech difficulty. If you have aura, avoid smoking and estrogen-containing contraception: both raise stroke risk. Preventives include magnesium, propranolol, and topiramate.
Abdominal migraine (recurring attacks of midline stomach pain with nausea, vomiting, and pallor, mostly in children) is treated like migraine: rest in a dark, quiet room, ibuprofen or acetaminophen, and antiemetics for acute attacks; propranolol, amitriptyline, or cyproheptadine for prevention. Other causes of abdominal pain must be excluded first.
Abdominal migraine is recognized by the ICHD-3 as a childhood migraine variant. Attacks last 2-72 hours with complete wellness between them, there is usually a strong family history of migraine, and many children go on to develop typical migraine headaches in adolescence. Because it is a diagnosis of exclusion, a pediatrician needs to rule out gastrointestinal, urinary, and surgical causes before it is treated as migraine. All drug treatment here is off-label and extrapolated from migraine care. Lifestyle is unusually powerful in children: regular sleep, regular meals, and hydration often outperform medication; the 2017 CHAMP trial found amitriptyline and topiramate no better than placebo in pediatric migraine. Botox has no role in children. See a pediatrician or pediatric neurologist.